Form DEFA14A Cytek Biosciences, Inc.
Tweet
Share
E-mailSCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
|
Filed by the Registrant
|
|
|
☒ |
|
Filed by a Party other than the Registrant
|
|
|
☐ |
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement
|
||||
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
||||
| ☐ |
Definitive Proxy Statement
|
||||
| ☒ |
Definitive Additional Materials
|
||||
| ☐ |
Soliciting Material Pursuant to § 240.14a-12
|
||||
Cytek Biosciences, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ |
No fee required.
|
| ☐ |
Fee paid previously with preliminary materials
|
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Survey: Nearly 40 Percent of Insulin Users Polled Pay More Than $150 Per Month
- Cadence Raises $100M Series C Led by Spark Capital to Automate Chronic Care
- CGI's Insula platform supports AI-driven Earth observation in ESA's Φsat-2 mission
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
